Table 1 Patient characteristics by CPP implementation status and referral status
| Â | Before CPP | During CPP | After CPP | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Total | Non-CPP referred | CPP referred | ||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
Total | 1202 | (100) | 4187 | (100) | 2336 | (100) | 1564 | (100) | 772 | (100) |
Deaths in three years | 695 | (57.8) | 2208 | (52.7) | 1165 | (49.9) | 775 | (49.6) | 390 | (50.5) |
Survival rate (raw) | ||||||||||
 1 year | 0.592 | 0.647 | 0.671 | 0.669 | 0.675 | |||||
 3 years | 0.413 | 0.471 | 0.501 | 0.505 | 0.495 | |||||
Sex | ||||||||||
 Woman | 624 | (51.9) | 2120 | (50.6) | 1128 | (48.3) | 782 | (50.0) | 346 | (44.8) |
 Man | 578 | (48.1) | 2067 | (49.4) | 1208 | (51.7) | 782 | (50.0) | 426 | (55.2) |
Age, median (IQI) | 68 | (58–77) | 68 | (59–76) | 68 | (59–76) | 68 | (59–76) | 68 | (60–76) |
Age groups (years) | ||||||||||
 18–44 | 84 | (7.0) | 258 | (6.2) | 141 | (6.0) | 102 | (6.5) | 39 | (5.1) |
 45–54 | 138 | (11.5) | 469 | (11.2) | 264 | (11.3) | 191 | (12.2) | 73 | (9.5) |
 55–64 | 293 | (24.4) | 1040 | (24.8) | 549 | (23.5) | 353 | (22.6) | 196 | (25.4) |
 65–74 | 337 | (28.0) | 1235 | (29.5) | 724 | (31.0) | 472 | (30.2) | 252 | (32.6) |
 75- | 350 | (29.1) | 1185 | (28.3) | 658 | (28.2) | 446 | (28.5) | 212 | (27.5) |
Diagnoses | ||||||||||
 CRC | 283 | (23.5) | 1073 | (25.6) | 629 | (26.9) | 405 | (25.9) | 224 | (29.0) |
 Lung | 280 | (23.3) | 1018 | (24.3) | 501 | (21.4) | 299 | (19.1) | 202 | (26.2) |
 Melanoma | 125 | (10.4) | 403 | (9.6) | 236 | (10.1) | 154 | (9.8) | 82 | (10.6) |
 Head & neck | 74 | (6.2) | 260 | (6.2) | 180 | (7.7) | 141 | (9.0) | 39 | (5.1) |
 Upper GI | 185 | (15.4) | 570 | (13.6) | 336 | (14.4) | 252 | (16.1) | 84 | (10.9) |
 Gynaecological | 141 | (11.7) | 484 | (11.6) | 250 | (10.7) | 186 | (11.9) | 64 | (8.3) |
 Urinary system | 114 | (9.5) | 379 | (9.1) | 204 | (8.7) | 127 | (8.1) | 77 | (10.0) |
Tumour stage | ||||||||||
 Local | 452 | (37.6) | 1530 | (36.5) | 868 | (37.2) | 596 | (38.1) | 272 | (35.2) |
 Regional | 219 | (18.2) | 807 | (19.3) | 458 | (19.6) | 289 | (18.5) | 169 | (21.9) |
 Distant | 330 | (27.5) | 1294 | (30.9) | 719 | (30.8) | 462 | (29.5) | 257 | (33.3) |
 Unknown/missing | 201 | (16.7) | 556 | (13.3) | 291 | (12.5) | 217 | (13.9) | 74 | (9.6) |
Comorbidity | ||||||||||
 None | 793 | (66.0) | 2913 | (69.6) | 1.636 | (70.0) | 1.064 | (68.0) | 572 | (74.1) |
 Moderate | 319 | (26.5) | 1051 | (25.1) | 563 | (24.1) | 394 | (25.2) | 169 | (21.9) |
 High | 90 | (7.5) | 223 | (5.3) | 137 | (5.9) | 106 | (6.8) | 31 | (4.0) |
Educational level | ||||||||||
 Low | 473 | (39.4) | 1874 | (44.8) | 897 | (38.4) | 587 | (37.5) | 310 | (40.2) |
 Medium | 421 | (35.0) | 1450 | (34.6) | 883 | (37.8) | 601 | (38.4) | 282 | (36.5) |
 High | 202 | (16.8) | 641 | (15.3) | 456 | (19.5) | 307 | (19.6) | 149 | (19.3) |
 Missing | 106 | (8.8) | 222 | (5.3) | 100 | (4.3) | 69 | (4.4) | 31 | (4.0) |
Household income | ||||||||||
 Low | 378 | (31.4) | 1323 | (31.6) | 778 | (33.3) | 505 | (32.3) | 273 | (35.4) |
 Medium | 363 | (30.2) | 1364 | (32.6) | 802 | (34.3) | 542 | (34.7) | 260 | (33.7) |
 High | 395 | (32.9) | 1360 | (32.5) | 753 | (32.2) | 513 | (32.8) | 239 | (31.0) |